Cleared Traditional

K921860 - MODIFICATION TO IV SPIKE

K921860 is an FDA 510(k) clearance for MODIFICATION TO IV SPIKE, manufactured by Mcgaw, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 141-day FDA review.

K921860 · Mcgaw, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
141d
Days
Class 2
Risk

K921860 is an FDA 510(k) clearance for the MODIFICATION TO IV SPIKE. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Mcgaw, Inc. (Irvine, US). The FDA issued a Cleared decision on July 30, 1992 after a review of 141 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Mcgaw, Inc. devices

FDA 510(k) Submission Details - K921860

510(k) Number K921860 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 11, 1992
Decision Date July 30, 1992
Days to Decision 141 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 129d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 682
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K921860.
CLAVE CONNECTOR
K915571 · Icu Medical, Inc. · Sep 1992
SOLUTION ADMINISTRATION SET
K921391 · Douglas Medical Products Corp. · Sep 1992
MERIT ADMINISTRATION SET
K915678 · Merit Medical Systems, Inc. · Jul 1992
CONTINU-FLO(R) SOLUTION SET
K921703 · Baxter Healthcare Corp · Jun 1992
INJECTION SITE WITH LUER LOCK
K915828 · Baxter Healthcare Corp · May 1992
RAPID ADD SITE DOUBLE LUMEN I.V.EXTENSION SET
K915109 · Ballard Medical Products · May 1992